{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,25]],"date-time":"2026-01-25T12:05:09Z","timestamp":1769342709880,"version":"3.49.0"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,6,5]],"date-time":"2020-06-05T00:00:00Z","timestamp":1591315200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,6,5]],"date-time":"2020-06-05T00:00:00Z","timestamp":1591315200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hormones"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1007\/s42000-020-00215-9","type":"journal-article","created":{"date-parts":[[2020,6,5]],"date-time":"2020-06-05T04:05:33Z","timestamp":1591329933000},"page":"161-165","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Onset of Marine-Lenhart syndrome and Graves\u2019 ophthalmopathy in a female patient treated with alemtuzumab for multiple sclerosis"],"prefix":"10.1007","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1398-9271","authenticated-orcid":false,"given":"Rosario","family":"Le Moli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Russo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pasqualino","family":"Malandrino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Veronica","family":"Vella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonino","family":"Belfiore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Frasca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,6,5]]},"reference":[{"key":"215_CR1","doi-asserted-by":"publisher","first-page":"213","DOI":"10.3803\/EnM.2016.31.2.213","volume":"31","author":"WM Wiersinga","year":"2016","unstructured":"Wiersinga WM (2016) Clinical relevance of environmental factors in the pathogenesis of autoimmune thyroid disease. Endocrinol Metab 31:213\u2013222","journal-title":"Endocrinol Metab"},{"key":"215_CR2","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1001\/jamaoncol.2017.3064","volume":"4","author":"R Barroso-Sousa","year":"2018","unstructured":"Barroso-Sousa R, Barry WT, Garrido-Castro AC et al (2018) Incidence of endocrine dysfunction following the use of different immune checkpoint inhibitor regimens: a systematic review and meta-analysis. JAMA Oncol 4:173\u2013182","journal-title":"JAMA Oncol"},{"key":"215_CR3","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1002\/cncr.31200","volume":"124","author":"R Barroso-Sousa","year":"2018","unstructured":"Barroso-Sousa R, Ott PA, Hodi FS et al (2018) Endocrine dysfunction induced by immune checkpoint inhibitors: practical recommendations for diagnosis and clinical management. Cancer 124:1111\u20131121","journal-title":"Cancer"},{"key":"215_CR4","doi-asserted-by":"publisher","first-page":"G1","DOI":"10.1530\/ERC-18-0320","volume":"26","author":"F Castinetti","year":"2019","unstructured":"Castinetti F, Albarel F, Archambeaud F et al (2019) French Endocrine Society Guidance on endocrine side effects of immunotherapy. Endocr Relat Cancer 26:G1\u2013G18","journal-title":"Endocr Relat Cancer"},{"key":"215_CR5","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1016\/S0140-6736(99)02429-0","volume":"354","author":"AJ Coles","year":"1999","unstructured":"Coles AJ, Wing M, Smith S et al (1999) Pulsed monoclonal antibody treatment and autoimmune thyroid disease in multiple sclerosis. Lancet 354:1691\u20131695","journal-title":"Lancet"},{"key":"215_CR6","doi-asserted-by":"publisher","first-page":"3010","DOI":"10.1210\/jc.2018-00359","volume":"103","author":"N Pariani","year":"2018","unstructured":"Pariani N, Willis M, Muller I et al (2018) Alemtuzumab-induced thyroid dysfunction exhibits distinctive clinical and immunological features. J Clin Endocrinol Metab 103:3010\u20133018","journal-title":"J Clin Endocrinol Metab"},{"key":"215_CR7","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1210\/jc.2013-2201","volume":"99","author":"GH Daniels","year":"2014","unstructured":"Daniels GH, Vladic A, Brinar V et al (2014) Alemtuzumab-related thyroid dysfunction in a phase 2 trial of patients with relapsing-remitting multiple sclerosis. J Clin Endocrinol Metab 99:80\u201389","journal-title":"J Clin Endocrinol Metab"},{"key":"215_CR8","doi-asserted-by":"publisher","first-page":"254","DOI":"10.3389\/fendo.2017.00254","volume":"8","author":"M Rotondi","year":"2017","unstructured":"Rotondi M, Molteni M, Leporati P et al (2017) Autoimmune thyroid diseases in patients treated with alemtuzumab for multiple sclerosis: an example of selective anti-TSH-receptor immune response. Front Endocrinol 8:254","journal-title":"Front Endocrinol"},{"key":"215_CR9","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1007\/s40618-019-01105-7","volume":"43","author":"L Scappaticcio","year":"2020","unstructured":"Scappaticcio L, Castellana M, Virili C et al (2020) Alemtuzumab-induced thyroid events in multiple sclerosis: a systematic review and meta-analysis. J Endocrinol Investig 43:219\u2013229","journal-title":"J Endocrinol Investig"},{"key":"215_CR10","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1007\/s13760-018-0883-2","volume":"118","author":"B Decallonne","year":"2018","unstructured":"Decallonne B, Bartholom\u00e9 E, Delvaux V et al (2018) Thyroid disorders in alemtuzumab-treated multiple sclerosis patients: a Belgian consensus on diagnosis and management. Acta Neurol Belg 118:153\u2013159","journal-title":"Acta Neurol Belg"},{"key":"215_CR11","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1001\/archinte.1911.00060090002001","volume":"8","author":"D Marine","year":"1911","unstructured":"Marine D, Lenhart CH (1911) Pathological anatomy of exophthalmic goiter: the anatomical and physiological relations of the thyroid gland to the disease; the treatment. Arch Intern Med 8:265\u2013316","journal-title":"Arch Intern Med"},{"key":"215_CR12","doi-asserted-by":"crossref","unstructured":"Neuman D, Kuker R, Vendrame F (2018) Marine-Lenhart syndrome: case report, diagnosis, and management. Case Rep Endocrinol 2018:","DOI":"10.1155\/2018\/3268010"},{"key":"215_CR13","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1530\/eje.1.02230","volume":"155","author":"WM Wiersinga","year":"2006","unstructured":"Wiersinga WM, Perros P, Kahaly GJ et al (2006) Clinical assessment of patients with Graves\u2019 orbitopathy: the European Group on Graves\u2019 Orbitopathy recommendations to generalists, specialists and clinical researchers. Eur J Endocrinol 155:387\u2013389","journal-title":"Eur J Endocrinol"},{"key":"215_CR14","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.7863\/jum.2008.27.12.1727","volume":"27","author":"R Malago","year":"2008","unstructured":"Malago R, D\u2019Onofrio M, Ferdeghini M et al (2008) Thyroid volumetric quantification: comparative evaluation between conventional and volumetric ultrasonography. J Ultrasound Med 27:1727\u20131733","journal-title":"J Ultrasound Med"},{"key":"215_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s40618-018-0871-7","volume":"42","author":"C Sparano","year":"2019","unstructured":"Sparano C, Parenti G, Cilotti A et al (2019) Clinical impact of the new SIAPEC-IAP classification on the indeterminate category of thyroid nodules. J Endocrinol Investig 42:1\u20136","journal-title":"J Endocrinol Investig"},{"key":"215_CR16","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1002\/art.23122","volume":"58","author":"AR Lorenzi","year":"2008","unstructured":"Lorenzi AR, Clarke AM, Wooldridge T et al (2008) Morbidity and mortality in rheumatoid arthritis patients with prolonged therapy-induced lymphopenia: twelve-year outcomes. Arthritis Rheum Off J Am Coll Rheumatol 58:370\u2013375","journal-title":"Arthritis Rheum Off J Am Coll Rheumatol"},{"key":"215_CR17","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1212\/WNL.0b013e318228bec5","volume":"77","author":"M Cossburn","year":"2011","unstructured":"Cossburn M, Pace AA, Jones J et al (2011) Autoimmune disease after alemtuzumab treatment for multiple sclerosis in a multicenter cohort. Neurology 77:573\u2013579","journal-title":"Neurology"},{"key":"215_CR18","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1111\/cen.12427","volume":"80","author":"AP Weetman","year":"2014","unstructured":"Weetman AP (2014) Graves\u2019 disease following immune reconstitution or immunomodulatory treatment: should we manage it any differently? Clin Endocrinol 80:629\u2013632","journal-title":"Clin Endocrinol"},{"key":"215_CR19","doi-asserted-by":"crossref","unstructured":"Abraham P, Avenell A, McGeoch SC, et al (2010) Antithyroid drug regimen for treating graves\u2019 hyperthyroidism. Cochrane Database Syst Rev","DOI":"10.1002\/14651858.CD003420.pub4"}],"container-title":["Hormones"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s42000-020-00215-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s42000-020-00215-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s42000-020-00215-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,4]],"date-time":"2021-06-04T23:05:48Z","timestamp":1622847948000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s42000-020-00215-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,5]]},"references-count":19,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["215"],"URL":"https:\/\/doi.org\/10.1007\/s42000-020-00215-9","relation":{},"ISSN":["1109-3099","2520-8721"],"issn-type":[{"value":"1109-3099","type":"print"},{"value":"2520-8721","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,5]]},"assertion":[{"value":"1 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors have no ethical conflict to disclose. The subject has given written informed consent to publish their case, including publication of images.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Statements of ethics"}},{"value":"The authors declare that they have no conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}